Upload Avatar (500 x 500)
Yan-Yan Meng
mengyan2293@whu.edu.cn
Chinese, English
Hubei
Wuhan University
Medical School
  • 2003.09-2010.07 Bachelor and Master of Clinical Medicine, Wuhan University
  • 2011.09-2018.12 PhD in Internal Medicine, Wuhan University
  • First Prize of Hubei Science and Technology Progress Award
  • 2010.07-2013.05 Resident Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
  • 2013.06-2019.11 Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
  • 2019.12-present Associate Chief Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
  • 2022.12-present Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University
  • 2019 First Prize of Hubei Science and Technology Progress Award
Myocardial remodeling
Cardiovascular disease prevention
  • Protection against Doxorubicin-Induced Cytotoxicity by Geniposide Involves AMPKα Signaling Pathway, Meng Yan-Yan, 2019
  • Geniposide protects against sepsis-induced myocardial dysfunction through AMPKα-dependent pathway, Meng Yan-Yan, 2020
  • Genistein attenuates pathological cardiac hypertrophy in vivo and in vitro, Meng Yan-Yan, 2019
  • Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes, Meng Yan-Yan, 2018
Myocardial Remodeling Cardiovascular Disease Prevention Mechanism Treatment Research Molecular Pathology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.